We studied 50 patients (41 male; median age 67, range 32-82 years) undergoing bronchoscopy for suspected malignancy. Trap specimens were taken and biopsy specimens obtained if a visible lesion was seen. Brush specimens were then taken with both types of brush (disposable rake and reusable bristle, Olympus), in random order, from each patient.
Bronchial brush biopsy has been in use for several decades' and is now used most commonly with the fibreoptic bronchoscope.2 Two main types of brush are available. The disposable rake type is enclosed in a plastic sheath, which is inserted through the bronchoscope. The brush is pushed out of the sheath to collect the specimen, and then withdrawn into the sheath before removal from the bronchoscope. The Four cytology slides were made as soon as the brush was removed from the patient, with the reusable brush still protruding from the bronchoscope if it had been used second. Two experienced cytologists (MJW and PDJ) examined the slides without knowledge of which brush had been used to obtain the specimens. For each slide they assessed whether an adequate specimen for cytological examination had been obtained and whether malignant cells were present, and they stated a preference for one or other set of slides.
Statistical comparisons were made by using the x2 test with Yates's correction.
Results
Carcinoma of the bronchus was the final diagnosis in 47 of the 50 patients. Thirty patients had macroscopic evidence of a tumour at bronchoscopy, and in a further 12 patients the appearances were suspicious but not diagnostic of malignancy. A pathological diagnosis of malignancy was made from the specimens taken at bronchoscopy in 37 patients. In two patients further investigation did not disclose any evidence of malignancy and one had a carcinoid tumour.
One or other brush provided a specimen that gave a positive diagnosis of malignancy in 34 patients, this being the only positive bronchoscopy specimen in seven. The cytologists found four sets of slides to contain inadequate material for cytological examination, two from each type of brush. They preferred the slides made from the disposable brush in 21 patients and from the reusable brush in 23 patients.
A diagnosis of malignancy was made with the disposable brush in 31 (62%) of patients and with the reusable brush in 28 (56%) (95% but real difference between the two types of brush.
Our conclusion that the diagnostic yield from the disposable brush was equivalent to that obtained with the reusable brush contrasts with our previous impression that the reusable brush was superior, and holds good irrespective of whether or not the reusable brush was withdrawn through the bronchoscope before the cytology slides were made. Most of the patients in our study had central tumours, but we see no reason to suppose that our findings would not apply to peripheral lesions also.
We are unaware of any instances of cross contamination of specimens or transmission of infection with cytology brushes. Mycobacterium chelonei has, however, been isolated from brushes used with a bronchoscope later found to harbour the organism and thought to have been damaged by bent cytology brushes, presumably of the reusable type.4 It takes 10-30 minutes to clean the reusable brush properly, and our nursing staff therefore prefer the disposable type. The disposable brush costs about £10. Each reusable brush costs slightly less than this and lasts for about 10 bronchoscopies. The introducer for the reusable brushes costs around £100 and lasts for about 100 procedures. Thus the cost of the reusable brush is about five times less per procedure than that of the disposable brush, though this does not take into account the cost of the nursing time needed for cleaning the brush. Since performing this study we have changed to the exclusive use of the disposable brush. 
